https://arstechnica.com/science/2020/09/national-institutes-of-health-disses-fda-on-plasma-as-covid-treatment/

Last week, the FDA announced that it was issuing an emergency use authorization for the treatment of COVID-19: the blood plasma of people who have recovered from a COVID-19 infection. But controversy quickly engulfed that announcement after it became clear that the head of the FDA had exaggerated the effectiveness of the treatment when explaining why it was being approved.